221 related articles for article (PubMed ID: 26610392)
21. Fine mapping analysis of a region of 20q13.33 identified five independent susceptibility loci for glioma in a Chinese Han population.
Song X; Zhou K; Zhao Y; Huai C; Zhao Y; Yu H; Chen Y; Chen G; Chen H; Fan W; Mao Y; Lu D
Carcinogenesis; 2012 May; 33(5):1065-71. PubMed ID: 22387365
[TBL] [Abstract][Full Text] [Related]
22. Interaction between 5 genetic variants and allergy in glioma risk.
Schoemaker MJ; Robertson L; Wigertz A; Jones ME; Hosking FJ; Feychting M; Lönn S; McKinney PA; Hepworth SJ; Muir KR; Auvinen A; Salminen T; Kiuru A; Johansen C; Houlston RS; Swerdlow AJ
Am J Epidemiol; 2010 Jun; 171(11):1165-73. PubMed ID: 20462933
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
Jin HJ; Jung S; DebRoy AR; Davuluri RV
Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of FRAT1 is associated with malignant phenotype and poor prognosis in human gliomas.
Guo G; Zhong CL; Liu Y; Mao XG; Zhang Z; Jin J; Liu J; Yang L; Mao JM; Guo YH; Zhao YL
Dis Markers; 2015; 2015():289750. PubMed ID: 25922553
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.
Shete S; Lau CC; Houlston RS; Claus EB; Barnholtz-Sloan J; Lai R; Il'yasova D; Schildkraut J; Sadetzki S; Johansen C; Bernstein JL; Olson SH; Jenkins RB; Yang P; Vick NA; Wrensch M; Davis FG; McCarthy BJ; Leung EH; Davis C; Cheng R; Hosking FJ; Armstrong GN; Liu Y; Yu RK; Henriksson R; ; Melin BS; Bondy ML
Cancer Res; 2011 Dec; 71(24):7568-75. PubMed ID: 22037877
[TBL] [Abstract][Full Text] [Related]
26. Association between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control Study.
Yang B; Heng L; Du S; Yang H; Jin T; Lang H; Li S
Med Sci Monit; 2015 Jul; 21():1983-8. PubMed ID: 26156397
[TBL] [Abstract][Full Text] [Related]
27. An in-depth analysis identifies two new independent signals in 11q23.3 associated with vitiligo in the Chinese Han population.
Zhao S; Fang F; Tang X; Dou J; Wang W; Zheng X; Sun L; Zhang A
J Dermatol Sci; 2017 Oct; 88(1):103-109. PubMed ID: 28551095
[TBL] [Abstract][Full Text] [Related]
28. Assessment of glioma risk associated with an inherited variant at chromosome 11q23.
Li Z; Wang Y; Guo X; Zhang L; Dong C; Zhang J
Cell Biochem Biophys; 2015 Jan; 71(1):69-75. PubMed ID: 25182002
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1.
Biancolella M; Fortini BK; Tring S; Plummer SJ; Mendoza-Fandino GA; Hartiala J; Hitchler MJ; Yan C; Schumacher FR; Conti DV; Edlund CK; Noushmehr H; Coetzee SG; Bresalier RS; Ahnen DJ; Barry EL; Berman BP; Rice JC; Coetzee GA; Casey G
Hum Mol Genet; 2014 Apr; 23(8):2198-209. PubMed ID: 24256810
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the FABP7 gene by PAX6 in malignant glioma cells.
Liu RZ; Monckton EA; Godbout R
Biochem Biophys Res Commun; 2012 Jun; 422(3):482-7. PubMed ID: 22583899
[TBL] [Abstract][Full Text] [Related]
31. DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis.
Yin J; Park G; Lee JE; Choi EY; Park JY; Kim TH; Park N; Jin X; Jung JE; Shin D; Hong JH; Kim H; Yoo H; Lee SH; Kim YJ; Park JB; Kim JH
Brain; 2015 Sep; 138(Pt 9):2553-70. PubMed ID: 26121981
[TBL] [Abstract][Full Text] [Related]
32. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Sano M; Genkai N; Yajima N; Tsuchiya N; Homma J; Tanaka R; Miki T; Yamanaka R
Oncol Rep; 2006 Nov; 16(5):1093-8. PubMed ID: 17016598
[TBL] [Abstract][Full Text] [Related]
33. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
Jenkins RB; Wrensch MR; Johnson D; Fridley BL; Decker PA; Xiao Y; Kollmeyer TM; Rynearson AL; Fink S; Rice T; McCoy LS; Halder C; Kosel ML; Giannini C; Tihan T; O'Neill BP; Lachance DH; Yang P; Wiemels J; Wiencke JK
Cancer Genet; 2011 Jan; 204(1):13-8. PubMed ID: 21356187
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
35. Chromosome conformation elucidates regulatory relationships in developing human brain.
Won H; de la Torre-Ubieta L; Stein JL; Parikshak NN; Huang J; Opland CK; Gandal MJ; Sutton GJ; Hormozdiari F; Lu D; Lee C; Eskin E; Voineagu I; Ernst J; Geschwind DH
Nature; 2016 Oct; 538(7626):523-527. PubMed ID: 27760116
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.
Foltz G; Ryu GY; Yoon JG; Nelson T; Fahey J; Frakes A; Lee H; Field L; Zander K; Sibenaller Z; Ryken TC; Vibhakar R; Hood L; Madan A
Cancer Res; 2006 Jul; 66(13):6665-74. PubMed ID: 16818640
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of colorectal-cancer-associated SNPs on the SMAD7 locus.
Liu Z; Zhao Y; Song H; Miao H; Wang Y; Tu C; Fu T; Qin J; Du B; Qian M; Ren H
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16659-16668. PubMed ID: 37721570
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide association study of glioma and meta-analysis.
Rajaraman P; Melin BS; Wang Z; McKean-Cowdin R; Michaud DS; Wang SS; Bondy M; Houlston R; Jenkins RB; Wrensch M; Yeager M; Ahlbom A; Albanes D; Andersson U; Freeman LE; Buring JE; Butler MA; Braganza M; Carreon T; Feychting M; Fleming SJ; Gapstur SM; Gaziano JM; Giles GG; Hallmans G; Henriksson R; Hoffman-Bolton J; Inskip PD; Johansen C; Kitahara CM; Lathrop M; Liu C; Le Marchand L; Linet MS; Lonn S; Peters U; Purdue MP; Rothman N; Ruder AM; Sanson M; Sesso HD; Severi G; Shu XO; Simon M; Stampfer M; Stevens VL; Visvanathan K; White E; Wolk A; Zeleniuch-Jacquotte A; Zheng W; Decker P; Enciso-Mora V; Fridley B; Gao YT; Kosel M; Lachance DH; Lau C; Rice T; Swerdlow A; Wiemels JL; Wiencke JK; Shete S; Xiang YB; Xiao Y; Hoover RN; Fraumeni JF; Chatterjee N; Hartge P; Chanock SJ
Hum Genet; 2012 Dec; 131(12):1877-88. PubMed ID: 22886559
[TBL] [Abstract][Full Text] [Related]
39. CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.
Adel Fahmideh M; Lavebratt C; Schüz J; Röösli M; Tynes T; Grotzer MA; Johansen C; Kuehni CE; Lannering B; Prochazka M; Schmidt LS; Feychting M
Carcinogenesis; 2015 Aug; 36(8):876-82. PubMed ID: 26014354
[TBL] [Abstract][Full Text] [Related]
40. Genetic advances in glioma: susceptibility genes and networks.
Liu Y; Shete S; Hosking F; Robertson L; Houlston R; Bondy M
Curr Opin Genet Dev; 2010 Jun; 20(3):239-44. PubMed ID: 20211558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
